Introduction
Insertional mutagenesis after gene transfer in animal models 1, 2 as well as in X-SCID clinical trials [3] [4] [5] has led numerous laboratories to focus on the safety of the virus-based vectors used to transfer and express genes of interest. A better understanding of the mechanisms that define the characteristics of the integration of virusbased vectors should allow the development of new vectors with increased biosafety. Taking advantage of the subgroup C feline leukemia virus (FeLV-C) as a platform for efficient transduction of target human cell types, including CD34+ stem and progenitor cells, we recently developed an FeLV-C-based packaging system named CatPac. HEK293 cells were engineered to stably package MoMLV vectors with FeLV 61E gag-pol gene products, in addition to FeLV-C Sarna env, resulting in a completely FeLV-derived packaging system. 6 In this study, we assessed the integration profile of CatPac vector in comparison with the same MoMLV vector packaged with MoMLV gag-pol and amphotropic env to elucidate the influence of the FeLV component packaging proteins on viral integration. Both primary vector sequences as well as integrase proteins have been implicated in genomic integration site (IS) selection for retroviruses, and thus we asked whether this hybrid vector might have a potentially less genotoxic integration pattern than standard MoMLV, because of the presence of the alternative FeLV integrase machinery. FeLV-C and MoMLV are both members of the mammalian C-type retrovirus family, but there is no previous information on the integration profile for either FeLV-C or hybrid MoMLV/FeLV packaging and vector systems.
Results and discussion
The results obtained for MoMLV are comparable to previously reported integration patterns for standard MoMLV-derived vectors. 10, 11 We confirmed the preference of MoMLV for integrating near the transcription start site (TSS), a feature also shared by CatPac vector. Like other retroviral vectors already studied such as MoMLV, 10, 11 ASLV, 12 SIV 10,13 and HIV, 12, 14 CatPac vector showed a profile of integration significantly different from random integrations as can be observed in all the tables and figures presented in this report. As shown in Figure 1 , out of the 114 CatPac vector and 112 MoMLV IS located in a window of 60 kb centered on TSSs, 44% (CatPac vector) and 35% (MoMLV) occurred in a 10 kb window centered on TSS, implicating a preference for integration near TSS. With regard to inter or intragenic insertions, Table 1 shows that approximately half of the vector integrations were found inside of a gene (49.5 and 54.3% for CatPac vector and MoMLV vectors, respectively). One quarter of all integrations were found within a 30 kb window upstream of a gene (Table 1 ). In these upstream regions CpG islands are motifs found in or in the vicinity of promoters. As shown in Table 2 integration of both vectors in or around ( ± 1 and ± 5 kb) CpG islands was significantly different from the random data sets. A quarter of the insertion sites were found ± 5 kb around CpG islands for CatPac (27.7%) and MoMLV (25.7%) vectors. However, this higher percentage probably represents the propensity of CatPac and MoMLV vectors to integrate close to the TSS, rather than a preference for CpG islands. Looking at integrations with regard to gene density, Table 2 shows that less than half of the integrations for both vectors were found in lower gene-density regions (0-10 genes Mb -1 ) of the genome, and thus 53.8 and 57.7% of integration respectively for CatPac and MoMLV vectors in gene dense regions (11 genes Mb -1 and up). Although this integration profile is significantly different from in silicogenerated integrations, there were no obvious differences in the integration pattern between CatPac and MoMLV vectors with respect to gene density.
Theoretically, virus-based vectors can lead to tumor formation by insertional mutagenesis either by activating an oncogene or by disrupting a tumor suppressor gene. 15 A majority of the, if not all, cases of malignant disease development after gene therapy for hematological disease have been associated with the activation of a proto-oncogene. [2] [3] [4] [5] We, therefore, looked at integration of CatPac and MoMLV vectors in the proximity of oncogenes (Table 3 ). We assessed both the proximity of proto-oncogenes to IS, and conversely the proximity of IS to proto-oncogenes. We defined proto-oncogenes based on the most recent version of the Sanger oncogene file (dated 16 December 2008, at http://www.sanger. ac.uk/genetics/CGP/Census/). Three hundred and eighty-four human entries were mapped to 368 unique Ensembl rhesus macaque gene identifiers. As shown in Figure 1 Distribution of ISs determined experimentally or in silico generated in a 60 kb window centered on transcription start sites (TSS). The window of 60 kb is subdivided into regions of 5 kb and percentage of ISs are reported for CatPac (black) and MoMLV (gray) vectors. 
Insertion site analysis of a hybrid (MoMLV/FeLV-C) retroviral vector in rhesus CD34+ Cells J-Y Métais et al Table 3 , with this size data set, the MoMLV integrations were not notably different from randoms with regard to proximity to oncogenes. However, the CatPac vector integrations were more likely than the random data sets to be in proximity to oncogenes. The 12 CatPac vector IS in or within a 30 kb window of an oncogene were located: upstream of MLLT11, MUTYH, CYTSB and LMO2; downstream of ARNT; in the intron of LASP1, Q4W6X8_MACMU, AKAP9, ERG, CBFB and PCM1; and in the exon of SUFU. The seven MoMLV IS were located: upstream of MLLT11 and TAL1; downstream of KRAS and STIL; in the intron of CDK6, PMS1 and CIITA. The only oncogene in proximity to both CatPac vector and MoMLV integrations was MLLT11, myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 11, also termed AF1q. Expression of this gene has been shown to be linked to poor prognosis in acute myeloid leukemia (reviewed in Gregory et al. 16 ) and has a function in apoptosis and drug resistance. We did not observe any integrations in or near the MDS1-EVI1 gene complex, previously reported to be over-represented in engrafting human, murine and rhesus macaque hematopoietic stem and progenitor cells transduced with MoMLV vectors. 17 Interestingly, in the 12 oncogenes targeted by the CatPac vector we found an integration 715 nucleotides upstream of LMO2, the gene activated in X-SCID trials and causing leukemia through a T-cell clonal expansion. [3] [4] [5] LMO2 was also reported as an MLV insertion site in the ADA-SCID and CGD gene therapy trials, but so far, no clonal expansion has been observed. [18] [19] [20] To analyze whether there was a significant clustering of vector insertions, we used the definition of common integration sites (CISs) reported by Suzuki et al. 21 As shown in Figure 2 , there is a difference between experimental data obtained for CatPac vector and random integrations. We found seven second-order CIS for CatPac vector, a higher value than the frequency of second-order CIS in the matching random data sets. None of the CIS identified were localized within 200 kb of a known proto-oncogene.
These investigations contribute to knowledge regarding the determinants of retrovirus integration into the genome. At least two vector-related elements are involved: the integrase/capsid proteins and/or the primary sequence of the vector backbone itself. The relative contributions of each element in determining integration preferences remain under intense investigation, but it appears that the integrase core region is critical. Swapping the integrase between even closely related viruses, such as human immunodeficiency virus and feline immunodeficiency virus, results in a Insertion site analysis of a hybrid (MoMLV/FeLV-C) retroviral vector in rhesus CD34+ Cells J-Y Métais et al change in the integration pattern determined primarily by the integrase, along with a contribution from gagencoded capsid proteins. 22, 23 The path of entry into the cell, determined by the env gene product, appears to have little effect on integration preferences. 24 In a previous study, pseudotyping of a standard MoMLV retroviral vector with the FeLV-C env protein only resulted in more efficient transduction of primitive CD34+ cells compared with a standard GALV env pseudotype, but no change in integration profile, based on a limited number of ISs retrieved from myeloid cells after in vivo engraftment. 25 In this study, we went on to study the effect of using [26] [27] [28] There are no large-scale integration profiles published for FeLV, however, CIS identification in tumors induced by FeLV infection indicate activation of an overlapping but not identical set of genes by FeLV as compared with MoMLV. 29 Swapping the U3 region of the MoLV LTR with the same region of FeLV results in a partial shift in CIS in tumors. 30 However, the integration profile of CIS in tumors may relate more to the enhancer activity of a specific U3 region in a target cell type as opposed to actual integration characteristics, because analysis of tumor CIS relies to a large degree on in vivo selection of clones with activating insertions, from an initial highly polyclonal pool of cells.
In conclusion, retroviral vectors packaged using the CatPac system integrate into the genome in a nonrandom manner, with a general profile very similar to vectors packaged using standard MoMLV gag and pol gene products, unfortunately characterized by a preference for integration within genes and near TSS. Although the study of a larger number of ISs might uncover subtle differences between FeLV and MoMLV integrase and capsid determinants of integration, it is clear from the data we obtained in this pilot study that their general profiles are similar and characterized by the same risks. Therefore, while CatPac vector may have advantages in terms of ease of high-titer vector production and potential improved efficiency of gene transfer to some target cell populations, the integration profile we have characterized does not suggest any increased safety of these vectors compared with standard retrovirus packaged with MoMLV components.
Materials and methods
Rhesus macaque CD34+ cells were obtained as described earlier. 7 Two rhesus macaques (RQ4984 and RQ4972) were treated with a combination of granulocyte colonystimulating factor and stem cell factor and mobilized 21 a second-order CIS is defined as two or more IS located within a 30 kb window; a third-order CIS as three or more IS within a 50 kb window; and a fourth-order CIS as four or more IS within a 100 kb window. The black solid arrow indicates the number of second-order CIS found in the experimental data set obtained for CatPac vector (7) . There was no third-order CIS found in the CatPac experimental data set. The solid gray and empty gray arrows respectively indicate the number of second-(3) and third-(1) order CIS found in the experimental data set for MoMLV. These numbers can be compared with the CIS obtained for the 10 000 independent random data sets generated in silico to match the CatPac and MoMLV data sets. The X axis gives the number of CIS and the Y axis gives the number of random data sets, out of 10 000, which included second-order (solid boxes) or third-order (empty boxes) CIS. Black and gray boxes respectively represent data obtained for random sets matching CatPac and MoMLV vectors. There was no fourth-order CIS found in any set (random or experimental). Linear PCR was carried out with biotinylated primer LTRa (Biot 5 0 -TGCTTACCACAGATATCCTG-3 0 ). The first exponential PCR was carried out with primer LCI (5 0 -GACCCGGGAGATCTGAAT-3 0 ) and LTR-R1 primer (5 0 -CAGCTGTTCCATCTGTTC-3 0 ), whereas the second exponential PCR was carried out with LCIII (5 0 -AGTG GCACAGCAGTTAGG-3 0 ) and LTR-R2 primer (5 0 -GCT AGCTTGCCAAACCTA-3 0 ). Sequences obtained were aligned by BLAST like alignment tool or basic local alignment search tool to the rhesus macaque genome assembly (Mmul 1.0, January 2006). We obtained 200 and 187 valid ISs for CatPac and MoMLV vectors respectively (Supplementary Information). Sites mapping to two or more genomic positions as well as sites mapping within repetitive genomic sequences were omitted to finally obtain 184 and 175 unique IS respectively for CatPac and MoMLV vectors. We also compared both profiles to in silico randomly generated IS sets as described earlier. 9 Briefly, 10 000 sets of 184 or 175 random IS were designed in silico as follows: an AATT (TasI) site in the genome was selected at random using a random number generator. The in silico IS was placed either upstream or downstream (P ¼ 0.5) of the AATT site, at a distance matching the size of one of the sequences obtained experimentally. The in silico IS was validated only when a BLAST alignment of the genomic sequence between the AATT and the IS returned a unique sequence in the genome. This operation was repeated 184 times and 175 times respectively for CatPac and MoMLV vectors to obtain a single matching random data set. These control data sets were subjected to the same analyses as the experimental data sets, and the results were used to generate empiric P-values. We generated two groups of control genomic coordinates, one with 10 000 sets of 184 coordinates each to mimic the CatPac vector IS, and one with 10 000 sets of 175 coordinates each to mimic the MoMLV IS. For gene annotation, Ensembl release 54 (May 2009) comprising 38 146 predicted gene transcripts were used. The association between the CatPac and MoMLV vectors ISs was tested using a w 2 test.
